SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-020455
Filing Date
2024-05-06
Accepted
2024-05-06 07:03:57
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20240331.htm   iXBRL 10-Q 638049
2 EX-31.1 fhtx-20240331xex311.htm EX-31.1 10247
3 EX-31.2 fhtx-20240331xex312.htm EX-31.2 10229
4 EX-32.1 fhtx-20240331xex321.htm EX-32.1 4292
5 EX-32.2 fhtx-20240331xex322.htm EX-32.2 4277
  Complete submission text file 0001628280-24-020455.txt   3782796

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20240331.xsd EX-101.SCH 28791
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20240331_cal.xml EX-101.CAL 47569
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20240331_def.xml EX-101.DEF 106734
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20240331_lab.xml EX-101.LAB 408067
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20240331_pre.xml EX-101.PRE 258844
59 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20240331_htm.xml XML 415448
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 24915511
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)